MarginsXMarginsX
Home › Markets › Health Care › PRCT

PROCEPT BioRobotics Corporation (PRCT)

PRCT trades on Nasdaq in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$23.54
-1.09% on the day
Market cap
$1.4B
Small cap
Revenue · 2025
$308.1M
+37.2% on 2024
Net income · 2025
-$95.6M
-31.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1588978/000158897826000009/0001588978-26-000009-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerPRCT on Nasdaq
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2021
SEC CIK0001588978
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$308.1M
Net income-$95.6M
Operating income-$103.9M
Net margin-31.0%
Operating margin-33.7%
Revenue growth+37.2%
Cash$286.5M
Total assets$508.1M
P/E (computed)Net income was not positive
P/S (computed)4.4×

Warning signs

Cash runway
34.2 months
$218.4M cash at September 30, 2026
Share count, 1 year
+3.0%
2025-10-29 to 2026-10-29 · +13.9% over 3 years
Going-concern doubt
No
10-Q filed November 4, 2026
Insider net buying, 12 months
$10.4M
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-04
Cash and burn$218.4M cash; operating cash flow -$19.2M a quarter.Report 2026-09-30
Shares outstanding57,536,121 (2026-10-29); 55,878,589 a year earlier; 50,498,621 three years earlier.Cover page 2026-10-29
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, San Jose, California, United StatesPCAOB Form AP 2026-03-09
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $11.0M, sold $616K on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$98.3M-$26.5M-$9.0M$218.4M$51.8M$352.3M10-Q 2026-11-04
Q2 2026
2026-06-30
$94.5M-$26.9M-$19.3M$227.9M$51.7M$337.3M10-Q 2026-08-05
Q1 2026
2026-03-31
$83.1M-$31.6M-$38.1M$245.6M$51.7M$322.0M10-Q 2026-04-30
Q4 2025
2025-12-31
$76.4M-$29.8M-$10.3M$286.5M$51.6M$308.1M10-K 2026-02-26
Q3 2025
2025-09-30
$83.3M-$21.4M-$6.6M$294.3M$51.6M$299.9M10-Q 2026-11-04
Q2 2025
2025-06-30
$79.2M-$19.6M-$15.0M$302.7M$51.5M$274.9M10-Q 2026-08-05
Q1 2025
2025-03-31
$69.2M-$24.7M-$17.0M$316.2M$51.5M$249.1M10-Q 2026-04-30
Q4 2024
2024-12-31
$68.2M-$18.9M-$32.4M$333.7M$51.5M$224.5M10-K 2026-02-26

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52024-10-30
Latest annual report10-K2026-02-26
Latest quarterly / interim10-Q2026-11-04
Latest current report8-K2026-11-04
Latest proxyDEFA14A2026-04-22

Source: SEC EDGAR submissions feed, 399 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+15.4%
1 month+24.6%
3 months+8.4%
Year to date-24.3%
1 year-21.8%
From 52-week high-34.1%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
NVCRNovoCure Limited$11.30-4.48%$1.3B
TNDMTandem Diabetes Care Inc.$18.48-7.92%$1.3B
DRTSAlpha Tau Medical Ltd.$11.97-10.54%$1.1B
KMTSKestra Medical Technologies Ltd.$27.97-2.34%$1.7B
IARTIntegra LifeSciences Holdings Corporation$13.98-2.92%$1.1B
IRMDiRadimed Corporation$84.84-0.60%$1.1B
SGPSpyGlass Pharma Inc.$32.24-1.95%$1.1B
INSPInspire Medical Systems Inc.$59.12-3.24%$1.7B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier